These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2104091)

  • 1. Effect of intra-colonic nicardipine on colonic motility in irritable bowel syndrome.
    Maxton DG; Whorwell PJ
    Aliment Pharmacol Ther; 1990 Jun; 4(3):305-8. PubMed ID: 2104091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of colonic motility by intravenous nicardipine in irritable bowel syndrome.
    Prior A; Harris SR; Whorwell PJ
    Gut; 1987 Dec; 28(12):1609-12. PubMed ID: 3428688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral nicardipine on anorectal function in normal human volunteers and patients with irritable bowel syndrome.
    Sun WM; Edwards CA; Prior A; Rao SS; Read NW
    Dig Dis Sci; 1990 Jul; 35(7):885-90. PubMed ID: 2364843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic myoelectrical activity in irritable-bowel syndrome. Effect of eating and anticholinergics.
    Sullivan MA; Cohen S; Snape WJ
    N Engl J Med; 1978 Apr; 298(16):878-83. PubMed ID: 345122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome.
    Niederau C; Faber S; Karaus M
    Gastroenterology; 1992 Jun; 102(6):1889-98. PubMed ID: 1587408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of postprandial colonic motility by sulpiride in patients with irritable colon.
    Lanfranchi GA; Bazzocchi G; Marzio L; Campieri M; Brignola C
    Eur J Clin Pharmacol; 1983; 24(6):769-72. PubMed ID: 6884414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of pinaverium bromide therapy on colonic motility disorders in irritable bowel syndrome].
    Wittmann T; Fehér A; Rosztóczy A; Jánosi J
    Orv Hetil; 1999 Feb; 140(9):469-73. PubMed ID: 10204402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction by cimetropium bromide of the colonic motor response to eating in patients with the irritable bowel syndrome.
    Lanfranchi GA; Bazzocchi G; Campieri M; Brignola C; Fois F; Imbimbo BP
    Eur J Clin Pharmacol; 1988; 33(6):571-5. PubMed ID: 3366160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Manometric effects of pinaverium bromide in irritable bowel syndrome].
    Soifer L; Varela E; Olmos J
    Acta Gastroenterol Latinoam; 1992; 22(1):37-43. PubMed ID: 1295286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of colonic motility by cholecystokinin.
    Mangel AW; Brazer SR; Smith JW; Fitz JG; Taylor IL
    Ann Med; 1992 Oct; 24(5):341-2. PubMed ID: 1418916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of post-prandial motility by pinaverium bromide a calcium channel blocker acting selectively on the gastrointestinal tract in patients with irritable bowel syndrome.
    Awad RA; Cordova VH; Dibildox M; Santiago R; Camacho S
    Acta Gastroenterol Latinoam; 1997; 27(4):247-51. PubMed ID: 9401097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Colonic microflora and motility. Physiological data and during irritable bowel syndrome].
    Coffin B
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C85-8. PubMed ID: 11787386
    [No Abstract]   [Full Text] [Related]  

  • 13. Colonic motility in the irritable bowel syndrome.
    Burns TW
    Arch Intern Med; 1980 Feb; 140(2):247-51. PubMed ID: 7352821
    [No Abstract]   [Full Text] [Related]  

  • 14. Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide.
    Narducci F; Bassotti G; Granata MT; Pelli MA; Gaburri M; Palumbo R; Morelli A
    Dig Dis Sci; 1986 Mar; 31(3):241-6. PubMed ID: 3948628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor effects of locally administered pinaverium bromide in the sigmoid tract of patients with irritable bowel syndrome.
    Passaretti S; Sorghi M; Colombo E; Mazzotti G; Tittobello A; Guslandi M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):47-50. PubMed ID: 2744907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome.
    Harvey RF; Read AE
    Lancet; 1973 Jan; 1(7793):1-3. PubMed ID: 4118538
    [No Abstract]   [Full Text] [Related]  

  • 17. Nifedipine reduces the colonic motor response to eating in patients with the irritable colon syndrome.
    Narducci F; Bassotti G; Gaburri M; Farroni F; Morelli A
    Am J Gastroenterol; 1985 May; 80(5):317-9. PubMed ID: 3993632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of domperidone and dopamine on colonic motor activity in patients with the irritable bowel syndrome.
    Lanfranchi GA; Bazzocchi G; Fois F; Brignola C; Campieri M; Menni B
    Eur J Clin Pharmacol; 1985; 29(3):307-10. PubMed ID: 4076326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of propranolol on colonic pressure in patients with irritable bowel syndrome.
    Abrahamsson H; Dotevall G
    Scand J Gastroenterol; 1981; 16(8):1021-4. PubMed ID: 7336128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of postprandial colonic motility after ingestion of an amino acid mixture.
    Battle WM; Cohen S; Snape WJ
    Dig Dis Sci; 1980 Sep; 25(9):647-52. PubMed ID: 7418588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.